Retrospective investigation of hospitalised patients with atrial fibrillation in mainland China

International Journal of Cardiology

Volumn 105, Issue 3, 2005, Pages 283-287

  Wen Hang, Q I ^a,b,c  

^a Shanghai Cardiovascular Association   (China)

^b Chinese Medical Association   (China)

^c SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Anti arrhythmic; Anticoagulant; Antiplatelet; Atrial fibrillation; Epidemiology; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGOXIN; PROPAFENONE; QUINIDINE; SOTALOL; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CARDIOMYOPATHY; CARDIOVERSION; CHINA; CONTROLLED STUDY; DATA ANALYSIS; DIABETES MELLITUS; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART RHYTHM; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATIC HEART DISEASE; RISK ASSESSMENT; RISK FACTOR; STROKE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CHINA; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 27744557972     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2004.12.042     Document Type: Article

References (10)

1. E. Braunwald Shattuck lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities N Engl J Med 337 1997 1360 1369
2. W.M. Feinberg, J.L. Blackshear, and A. Laupacis Prevalence, age, distribution and gender of patients with atrial fibrillation Arch Intern Med 155 1995 469 473
3. A.D. Krahn, J. Manfreda, and R.B. Tate The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba follow-up study Am J Med 98 1995 476 484
4. V. Fuster, L.E. Ryden, and R.W. Asinger ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation J Am Col Cardiol 38 2001 1 70
5. G. Cotter, A. Blatt, and E. Kaluski Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone Eur Heart J 20 1999 1833 1842
6. D.G. Wyse, A.L. Waldo, and J.P. DiMarco Atrial fibrillation follow-up investigation of rhythm management (AFFIRM) investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833
7. M. Brignole, L. Gianfranchi, and C. Menozzi Assessment of atrioventricular function ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: a randomized controlled study Circulation 96 1997 2617 2624
8. P. Peterson, G. Boysen, J. Godtfredsen, E.D. Andersen, and B. Andersen Placebo-controlled randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study Lancet 1 1989 175 179
9. S.D. Fihn, C.M. Callahan, and D.C. Martin The risk for and severity of bleeding complications in elderly patients treated with warfarin national consortium of anticoagulation clinics Ann Intern Med 124 1996 970 979
10. L.A. Pearce, R.G. Hart, and J.L. Halperin Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation Am J Med 109 2000 45 51